Is Viemed Healthcare Stock a Good Investment?
Viemed Healthcare Investment Advice | VMD |
- Examine Viemed Healthcare's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Viemed Healthcare's leadership team and their track record. Good management can help Viemed Healthcare navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Viemed Healthcare's business and its evolving consumer preferences.
- Compare Viemed Healthcare's performance and market position to its competitors. Analyze how Viemed Healthcare is positioned in terms of product offerings, innovation, and market share.
- Check if Viemed Healthcare pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Viemed Healthcare's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Viemed Healthcare stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Viemed Healthcare is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Good | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Viemed Healthcare Stock
Researching Viemed Healthcare's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 13.0% of the company outstanding shares are owned by insiders. The book value of Viemed Healthcare was at this time reported as 3.21. The company had not issued any dividends in recent years.
To determine if Viemed Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Viemed Healthcare's research are outlined below:
| Viemed Healthcare has a strong financial position based on the latest SEC filings | |
| About 67.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from investing.com: Viemed Healthcare director sells shares worth 255,900 |
Viemed Healthcare Quarterly Accounts Payable |
|
Viemed Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Viemed Healthcare. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Viemed Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Viemed Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Viemed Healthcare's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-03-06 | 2023-12-31 | 0.1 | 0.09 | -0.01 | 10 | ||
2023-08-09 | 2023-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2022-05-03 | 2022-03-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2021-08-02 | 2021-06-30 | 0.03 | 0.04 | 0.01 | 33 | ||
2020-11-04 | 2020-09-30 | 0.08 | 0.07 | -0.01 | 12 | ||
2020-03-03 | 2019-12-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2019-11-04 | 2019-09-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2019-08-09 | 2019-06-30 | 0.06 | 0.05 | -0.01 | 16 |
Know Viemed Healthcare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Viemed Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Viemed Healthcare backward and forwards among themselves. Viemed Healthcare's institutional investor refers to the entity that pools money to purchase Viemed Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Awm Investment Company Inc | 2024-09-30 | 612.9 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 539 K | Tocqueville Asset Management L.p. | 2024-09-30 | 417.1 K | Raffles Associates Lp | 2024-09-30 | 402.7 K | Paradigm Capital Management, Inc. | 2024-06-30 | 400 K | Renaissance Technologies Corp | 2024-09-30 | 364.6 K | Divisadero Street Capital Management, Lp | 2024-09-30 | 349.8 K | Cove Street Capital, Llc | 2024-09-30 | 349.2 K | Bard Associates Inc | 2024-09-30 | 345.1 K | Thrivent Financial For Lutherans | 2024-09-30 | 3.4 M | Blackrock Inc | 2024-06-30 | 2.9 M |
Viemed Healthcare's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 340.7 M.Market Cap |
|
Viemed Healthcare's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.08 | |
| Return On Capital Employed | 0.12 | 0.11 | |
| Return On Assets | 0.07 | 0.06 | |
| Return On Equity | 0.09 | 0.09 |
Determining Viemed Healthcare's profitability involves analyzing its financial statements and using various financial metrics to determine if Viemed Healthcare is a good buy. For example, gross profit margin measures Viemed Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Viemed Healthcare's profitability and make more informed investment decisions.
Please note, the presentation of Viemed Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Viemed Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Viemed Healthcare's management manipulating its earnings.
Evaluate Viemed Healthcare's management efficiency
Viemed Healthcare has Return on Asset of 0.0686 % which means that on every $100 spent on assets, it made $0.0686 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0888 %, implying that it generated $0.0888 on every 100 dollars invested. Viemed Healthcare's management efficiency ratios could be used to measure how well Viemed Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. As of November 25, 2024, Return On Tangible Assets is expected to decline to 0.08. In addition to that, Return On Capital Employed is expected to decline to 0.11. At present, Viemed Healthcare's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 684.7 K, whereas Non Currrent Assets Other are forecasted to decline to about 842.6 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.97 | 3.12 | |
| Tangible Book Value Per Share | 2.18 | 1.12 | |
| Enterprise Value Over EBITDA | 8.14 | 12.56 | |
| Price Book Value Ratio | 2.64 | 3.98 | |
| Enterprise Value Multiple | 8.14 | 12.56 | |
| Price Fair Value | 2.64 | 3.98 | |
| Enterprise Value | 298.6 M | 313.5 M |
Viemed Healthcare has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Beta 1.436 |
Basic technical analysis of Viemed Stock
As of the 25th of November, Viemed Healthcare has the Risk Adjusted Performance of 0.125, semi deviation of 1.66, and Coefficient Of Variation of 645.35. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viemed Healthcare, as well as the relationship between them. Please validate Viemed Healthcare information ratio, as well as the relationship between the value at risk and expected short fall to decide if Viemed Healthcare is priced more or less accurately, providing market reflects its prevalent price of 8.65 per share. Given that Viemed Healthcare has jensen alpha of 0.1432, we advise you to double-check Viemed Healthcare's current market performance to make sure the company can sustain itself at a future point.Viemed Healthcare's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Viemed Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Viemed Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Viemed Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Viemed Healthcare's Outstanding Corporate Bonds
Viemed Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Viemed Healthcare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Viemed bonds can be classified according to their maturity, which is the date when Viemed Healthcare has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View |
Understand Viemed Healthcare's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Viemed Healthcare's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.125 | |||
| Market Risk Adjusted Performance | 0.2402 | |||
| Mean Deviation | 1.52 | |||
| Semi Deviation | 1.66 | |||
| Downside Deviation | 1.85 | |||
| Coefficient Of Variation | 645.35 | |||
| Standard Deviation | 2.01 | |||
| Variance | 4.04 | |||
| Information Ratio | 0.0899 | |||
| Jensen Alpha | 0.1432 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0978 | |||
| Treynor Ratio | 0.2302 | |||
| Maximum Drawdown | 10.98 | |||
| Value At Risk | (2.76) | |||
| Potential Upside | 3.3 | |||
| Downside Variance | 3.41 | |||
| Semi Variance | 2.75 | |||
| Expected Short fall | (1.66) | |||
| Skewness | 0.4933 | |||
| Kurtosis | 1.34 |
| Risk Adjusted Performance | 0.125 | |||
| Market Risk Adjusted Performance | 0.2402 | |||
| Mean Deviation | 1.52 | |||
| Semi Deviation | 1.66 | |||
| Downside Deviation | 1.85 | |||
| Coefficient Of Variation | 645.35 | |||
| Standard Deviation | 2.01 | |||
| Variance | 4.04 | |||
| Information Ratio | 0.0899 | |||
| Jensen Alpha | 0.1432 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0978 | |||
| Treynor Ratio | 0.2302 | |||
| Maximum Drawdown | 10.98 | |||
| Value At Risk | (2.76) | |||
| Potential Upside | 3.3 | |||
| Downside Variance | 3.41 | |||
| Semi Variance | 2.75 | |||
| Expected Short fall | (1.66) | |||
| Skewness | 0.4933 | |||
| Kurtosis | 1.34 |
Consider Viemed Healthcare's intraday indicators
Viemed Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Viemed Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Viemed Healthcare Corporate Filings
F4 | 21st of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 14th of November 2024 Other Reports | ViewVerify | |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 8th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Viemed Stock media impact
Far too much social signal, news, headlines, and media speculation about Viemed Healthcare that are available to investors today. That information is available publicly through Viemed media outlets and privately through word of mouth or via Viemed internal channels. However, regardless of the origin, that massive amount of Viemed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Viemed Healthcare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Viemed Healthcare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Viemed Healthcare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Viemed Healthcare alpha.
Viemed Healthcare Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Viemed Healthcare can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Viemed Healthcare Corporate Management
| William Zehnder | COO Director | Profile | |
| Robert LLB | Co Sec | Profile | |
| Jeremy Trahan | Chief Transactions | Profile | |
| Patrick Eagan | General Secretary | Profile | |
| William MD | Chief Director | Profile | |
| Casey Hoyt | CEO Director | Profile | |
| Michael Freeman | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viemed Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Earnings Share 0.25 | Revenue Per Share 5.534 | Quarterly Revenue Growth 0.174 | Return On Assets 0.0686 |
The market value of Viemed Healthcare is measured differently than its book value, which is the value of Viemed that is recorded on the company's balance sheet. Investors also form their own opinion of Viemed Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Viemed Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viemed Healthcare's market value can be influenced by many factors that don't directly affect Viemed Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Viemed Healthcare's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.